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Primary microcephaly is a genetically heterogeneous condition
characterized by reduced head circumference (3 SDS or more)
and mild-to-moderate learning disability. Here, we describe
clinical and molecular investigations of a microcephalic child
with sensorineural hearing loss. Although consanguinity was
unreported initially, detection of 13.7Mb of copy neutral loss of
heterozygosity (cnLOH) on chromosome 9 implicated the
CDK5RAP2 gene. Targeted sequencing identiﬁed a homozygous
E234X mutation, only the third mutation to be described in
CDK5RAP2, the ﬁrst in an individual of non-Pakistani descent.
Sensorineural hearing loss is not generally considered to be
consistent with autosomal recessive microcephaly and therefore
it seems likely that the deafness in this individual is caused by the
co-occurrence of a further gene mutation, independent of
CDK5RAP2. Nevertheless, further detailed clinical descriptions
of rare CDK5RAP2 patients, including hearing assessments will
be needed to resolve fully the phenotypic range associated with
mutations in this gene. This study also highlights the utility of
SNP-array testing to guide disease gene identiﬁcation where an
autosomal recessive condition is plausible.
 2012 Wiley Periodicals, Inc.
Key words: CDK5RAP2; MCPH3; microcephaly; deafness; SNP
array
INTRODUCTION
Mutations in ASPM and WDR62 account for the majority of
patients with primary microcephaly [Bond et al., 2002; Nicholas
et al., 2010]. Five other causative genes are known but have only
been reported in a few individuals (for recent review see [Mahmood
et al., 2011]). A recent study suggests CEP135 may be responsible
for an eighth microcephaly locus on chromosome 4q12 [Hussain
et al., 2012]. The fact that the majority of these microcephaly genes
were mapped using consanguineous kindreds from Pakistan high-
lights the importance of the autozygosity mapping strategy in the
Grant sponsor: Department ofHealth’s NIHRBiomedical ResearchCentre
Funding Scheme; Grant sponsor: FWF; Grant number: P21092; Grant
sponsor: Wellcome Trust; Grant number: 090532/Z/09/Z.
Informed consent was obtained from the family and the study was
approved by the Scottish Multicentre Research Ethics Committee
(04:MRE00/19) and the Wales Research Ethics Committee [08/MRE09/
55]. The authors declare no conﬂicts of interest.
*Correspondence to:
Samantha J.L. Knight, NIHRBiomedical ResearchCentre,WellcomeTrust
Centre forHumanGenetics,University ofOxford,RooseveltDrive,Oxford
OX3 7BN, UK. E-mail: sknight@well.ox.ac.uk
Article ﬁrst published online in Wiley Online Library
(wileyonlinelibrary.com): 10 August 2012
DOI 10.1002/ajmg.a.35558
How to Cite this Article:
Pagnamenta AT, Murray JE, Yoon G, Akha
ES, Harrison V, Bicknell LS, Ajilogba K,
Stewart H, Kini U, Taylor JC, Keays DA,
Jackson AP, Knight SJL. 2012. A novel
nonsense CDK5RAP2 mutation in a Somali
child with primary microcephaly and
sensorineural hearing loss.
Am J Med Genet Part A 158A:2577–2582.
 2012 Wiley Periodicals, Inc. 2577
understanding of this rare condition. However, as a consequence,
it is unclear what clinical relevance these genes have in other
populations.
CDK5RAP2 is responsible for one of the rarest forms of primary
microcephaly (MCPH3), with only two different mutations
published to date, in three independent families originating
from northern Pakistan [Bond et al., 2005; Hassan et al., 2007]
(Table I). A recent study of primarymicrocephaly patients from112
consanguineous Iranian pedigrees did not show any linkage to this
locus, indicating that CDK5RAP2 mutations may be rare even in
consanguineous families [Darvish et al., 2010]. In common with
other microcephaly genes, CDK5RAP2 appears to be involved with
centrosomal function: an inversion mutation in mice leads to
abnormal spindle poles, spontaneous aneuploidy and neurogenic
defects, resulting in microcephaly in some strains [Lizarraga et al.,
2010]. There is also evidence that CDK5RAP2 has undergone
positive selection and may have been a genetic factor leading to
the evolutionary increase in human brain size [Montgomery et al.,
2011].
Here, we describe an individual of Somali descent with primary
microcephaly and sensorineural hearing loss. Although the
family was initially reported to be non-consanguineous,
detection of two regions of copy neutral loss of heterozygosity
(cnLOH) led to further molecular investigation of the CDK5RAP2
gene.
CLINICAL REPORT
The patient was born to Somali parents at 40 weeks gestation,
weighing 2.37 kg (2.39 SDS) with an occipito-frontal head
circumference (OFC) of 30cm (3.68 SDS) and length of 43 cm
(3.68 SDS). Auditory brainstem response testing at 3 days of
life was normal. Although there were no neonatal problems, she
experienced signiﬁcant gastro-oesophageal reﬂux during the ﬁrst
4 months and was fed via a gastrostomy (aged 9 months). Early
developmental milestones were delayed. A brain MRI performed
at 15 months showed microcephaly but no structural abnor-
malities (Fig. 1A). Development was assessed aged 3 using the
Vineland Adaptive Behaviour scale: function was between the 1st
and 6th percentiles for various domains of development with
communication, motor, and composite adaptive behavior skills
on the 1st centile and social and daily living skills on the 6th and
5th centiles, respectively. Moderate-to-severe bilateral sensorineu-
ral hearing loss was diagnosed at 3 years, 10 months. Molecular
testing of GJB2 and GJB6 was normal. Although language skills
progressed following the introduction of hearing aids, at 6 years she
communicates largely by gestures. She is described as a happy,
sociable child with no reported behavioral problems. At 6 years,
growth parameters were: weight 17.6 kg (1.12 SDS), height
107.5 cm (1.61 SDS), and OFC 41.5 cm (8.91 SDS), with a
sloping forehead (Fig. 1B). There was mild joint laxity, hypotonia,
and decreased muscle bulk. No maternal or environmental
causes were identiﬁed that may have contributed to the micro-
cephaly or deafness. Given the absence of associatedmalformations
or neurological deﬁcits, a clinical diagnosis of primary micro-
cephaly was made. ASPM was sequenced but no mutations were
identiﬁed.
MATERIALS AND METHODS
Genotyping
With appropriate ethical approval and consent, DNA from the
patient and mother were genotyped using the CytoSNP-12 v2.1
array (Illumina Inc., SanDiego, CA).DNA from the patient’s father
could not be obtained. Data analysis was performed with Nexus
v5.1 Discovery Edition (BioDiscovery, Hawthorne, CA) and
GenomeStudio V2009.2 (Illumina).
Sequencing
All 38 exons and intron–exon boundaries of the CDK5RAP2
gene were ampliﬁed using the FastStart Taq DNA polymerase
(Roche, Burgess Hill, UK) and primers from a previous study
[Hassan et al., 2007]. PCR products were puriﬁed using
exonuclease I (NEB, Ipswich, MA) and shrimp alkaline phospha-
tase (USB, Cleveland, OH). Bidirectional Sanger sequencing was
then performed using BigDye chemistry (Applied Biosystems,
Foster City, CA) and run on a 3730xl DNA Analyzer (Applied
Biosystems).
RESULTS
The genome-wide SNP analysis did not reveal any copy number
variants (CNVs) in the patient, other than those noted already in
the Database of Genomic Variants. However, two large tracts of
cnLOH involving chr7p15.2–p21.3 and chr9q33.1–q34.12
(Fig. 1C) were noted of greater than 5Mb. These were not observed
in the mother. Co-occurrence of two independent cnLOH regions
led us to consider an unreported consanguineous parental relation-
ship. The coefﬁcient of inbreeding (fraction of the genome showing
cnLOH)was estimated tobe1/95, consistentwithparentswhoare
second-cousins or second-cousins-once-removed. Subsequent re-
evaluation of family-history established that parents were indeed
second-cousins (Fig. 1D).
Of the eight known microcephaly genes, one (CDK5RAP2) is
situated within the candidate region on chr9q33.1–q34.12. Tar-
geted sequencing of this gene revealed three homozygous coding
changes. Two of these were common missense polymorphisms
(rs4837768 and rs4836822), whereas the third was a novel nucleo-
tide transversion in exon 8 (c.700G>T, NM_018249.4) that pre-
dicts a premature stop at codon 234 (Fig. 1E). The variant was
heterozygous in the mother but was not seen in>5,000 Caucasian
and African-American samples in the Exome Variant Server
(http://evs.gs.washington.edu/EVS/; v.0.0.10).
We next considered the possibility that one of the cnLOH
loci might harbor a second rare mutation, in a deafness gene. In
addition to the large regions of cnLOH on chr7p and chr9q, ﬁve
other cnLOH loci of intermediate size (2–5Mb) were identiﬁed.
These were located at 3p24.3, 4q26, 5q21.1, 16p11.2 (peri-
centromeric region), and Xq22.3. We searched these seven loci
for genes noted in OMIM as being linked with deafness and
although we identiﬁed four genes (DFNA5, HOXA2, COL4A5,
and PRPS1), none of these appeared to be a likely candidate
based on their inheritance pattern or because the phenotype of
our patient did not match.
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DISCUSSION
To date, only two disease-causing mutations in CDK5RAP2 have
been described, both in consanguineous families; a Y82Xmutation
[Bond et al., 2005;Hassan et al., 2007] and a IVS26-15A>G splicing
mutation [Bond et al., 2005] (Table I). All three published families
are fromNorthern Pakistan. Therefore, our report of a Somali child
with primary microcephaly and a novel E234X mutation conﬁrms
CDK5RAP2 as a disease gene with clinical relevance outside the
Pakistani population.
Common features of patients with CDK5RAP2 mutations
include microcephaly from birth (4 to 8 SDS), with mild-to-
moderate learning disability (Table I). All have a short sloping
forehead but otherwise there do not appear to be any other
dysmorphic features or associated malformations in common.
Notably, our patient has signiﬁcant bilateral sensorineural hearing
loss. This manifestation is not generally considered to be consistent
with autosomal recessive microcephaly and therefore it is highly
possible that the deafnessmaybe causedby a further genemutation,
independent of CDK5RAP2. We speculated that such a mutation,
in a consanguineous family like this, might be recessive, caused by
an additional homozygous mutation. However, when we scanned
the seven cnLOH regions for phenotypes entered in OMIM, we
identiﬁed only one autosomal recessive hearing loss phenotype
(OMIM #612290: microtia, hearing impairment, and cleft palate
caused byHOXA2mutations), which did notmatch the phenotype
of our patient. There were two deafness genes on Xq22.3; COL4A5
which is implicated inAlport syndromewith variable sensorineural
hearing loss [Barker et al., 1990] and PRPS1 which is mutated in
non-syndromic X-linked deafness-1 [Liu et al., 2010]. However,
since all ﬁve siblings of the proband (two males and three females)
and her parents are clinically normal, we believe that both genes are
FIG. 1. A: Sagittal T1SE MRI images of patient at 15 months (on left) compared to a normal age- and gender-matched child (on right), demonstrating
cranio-facial disproportion characteristic of microcephaly. B: Photographs taken at age 6 years, shown with parental consent, indicating
microcephaly and sloping forehead. C: SNP-array data for chromosome 9 showing a 13.7 Mb region of copy-neutral loss of heterozygosity at
chr9:120,050,463–133,809,775 (GRCh19/hg37). In combination with a second region of cnLOH (chr7:9,870,471–27,658,801), the coefﬁcient of
inbreeding was estimated to be1/95. D: Simpliﬁed pedigree showing that the parents of the patient are second-cousins. Black shading indicates
primary microcephaly and hearing loss. The patient is the ﬁfth child in a sibship of six. We note that the male–male link in this consanguineous loop
means that the homozygous region on Xq22.3 is unlikely to have come from these great-great-grandparents. E: Sanger sequencing identiﬁed a
homozygous chr9:123,292,381C>A mutation, inherited from the heterozygous mother. Electropherogram shows sequence on the negative (i.e.,
coding) strand so mutation appears as G>T and predicts a Glu! STOP codon. DNA from the father and the patient’s siblings was not available.
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unlikely candidates for the progressive sensorineural hearing loss
noted in the proband. We also identiﬁed an autosomal dominant
non-syndromic sensorineural deafness phenotype (OMIM
#600994 caused by DFNA5 mutations) and we have not ruled
out the possibility of a de novo mutation in this or other dominant
deafness genes in our patient. Other explanations for the deafness
include the existence of a novel recessive deafness gene located in
one of the cnLOH regions. Alternatively, there is a possibility of
compoundheterozygousmutations elsewhere in the genomewhich
would not have been detected by our autozygosity mapping
approach. Interestingly, a recent study unexpectedly detected
multiple disease alleles at the DFNB3 locus within a single con-
sanguineous pedigree [Lezirovitz et al., 2008]. The increasing use
of exome sequence data now allows ﬁltering for genetic variants
that are compatible for multiple disease mechanisms and a recent
study used this method to resolve a complex case of Miller syn-
drome to be a combination of two different genetic disorders
[Ng et al., 2010].
The hearing loss present in individual VI:3 published previously
[Moynihan et al., 2000] prompted us to also consider the
possibility that CDK5RAP2 mutations might have variable
expressivity and that this might extend to include sensorineural
hearing loss. However, in the case described previously, the
deafness was congenital, whereas our patient passed a hearing
test at birth, suggesting different etiologies. Nevertheless, we
cannot rule out a link based on these cases alone and therefore
further detailed clinical descriptions of rare CDK5RAP2
patients, including hearing assessments, will be needed to help
resolve the full phenotypic range associated with mutations in
this gene.
In a recent array-CGH study, 22% of subjects with brain
malformations carried rare CNVs, many of which are likely to
have etiological relevance [Kariminejad et al., 2011]. In our study,
insufﬁcient DNA was available for standard array-CGH.
The decision to test the patient using a SNP-array (requiring
signiﬁcantly less DNA) instead proved fortuitous and highlights
the advantage of SNP-arrays over array-CGH platforms in helping
to guide targeted sequencing efforts, especially in cases where a
condition is suspected to be recessive and parental consanguinity
is a possibility. Whilst both platforms can detect pathogenic
CNVs, only the SNP platform can detect all forms of cnLOH
[Bruno et al., 2011], inform subsequent targeted sequencing
strategies and if needed, conﬁrm family relationships through
SNP genotypes. In this way, SNP-array testing can also act as
an invaluable prescreening and supportive tool when embarking
on expensive whole genome and exome sequencing studies. How-
ever, it should be cautioned that using genomic data to infer
family relationships can be a sensitive issue [Schaaf et al., 2011]
and appropriate genetic counseling should be provided prior to
testing.
In summary,we identiﬁed anovelCDK5RAP2mutation, theﬁrst
in a patient of non-Pakistani descent. Our study conﬁrms
CDK5RAP2 is a rare primary microcephaly disease gene and
emphasizes that when no consanguinity is reported but is sus-
pected, SNP-array testing can reveal cnLOH that may infer
distant relationships between parents and guide disease gene
identiﬁcation.
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